GYRE

Quote

Short

News

Articles

Message Board

Gyre Therapeutics Inc. (NASDAQ : GYRE ) News

Gyre Therapeutics Inc. (NASDAQ: GYRE) News Releases

GYRE News Releases

May 27, 2026 08:01:00 pm

TMX Newsfile

Kaskela Law LLC Announces Investigation of Gyre Therapeutics, Inc. (GYRE) and Encourages Long-Term GYRE Shareholders to Contact the Firm

May 12, 2026 04:05:00 pm

GlobeNewswire

Gyre Therapeutics Announces NMPA Acceptance of New Drug Application for F351 (hydronidone) for CHB-Induced Liver Fibrosis Treatment

May 07, 2026 06:23:23 am

SeekingAlpha

Gyre Therapeutics GAAP EPS of -$0.10, revenue of $22.5M

May 07, 2026 06:00:00 am

GlobeNewswire

Gyre Therapeutics Reports First Quarter 2026 Results and Provides Business Update

May 04, 2026 08:47:47 am

GlobeNewswire

Gyre Therapeutics Completes Acquisition of Cullgen to Create U.S.- and China-based Fully Integrated Biopharmaceutical Company

March 17, 2026 07:00:00 am

GlobeNewswire

Gyre Therapeutics Announces China's NMPA Grants Priority Review to the NDA for Hydronidone (F351) for CHB-Induced Liver Fibrosis Treatment

March 13, 2026 05:30:50 am

US Earnings Reports

Expected earnings - Gyre Therapeutics Inc.

March 12, 2026 06:10:21 am

SeekingAlpha

Gyre Therapeutics GAAP EPS of -$0.02 misses by $0.09, revenue of $37.2M beats by $1.76M

March 12, 2026 06:00:00 am

GlobeNewswire

Gyre Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

March 02, 2026 08:00:00 am

GlobeNewswire

Gyre Therapeutics Enters into Agreement to Acquire Cullgen to Gain Targeted Protein Degradation Platform and Pipeline

	Next 10

Subscribe to Our Newsletter

Download The Market Wire News App

Link Market Wire News to Your X Account